Skip to main content
Top
Published in: Intensive Care Medicine 8/2012

01-08-2012 | Original

Value of β-d-glucan and Candida albicans germ tube antibody for discriminating between Candida colonization and invasive candidiasis in patients with severe abdominal conditions

Authors: Cristóbal León, Sergio Ruiz-Santana, Pedro Saavedra, Carmen Castro, Alejandro Úbeda, Ana Loza, Estrella Martín-Mazuelos, Armando Blanco, Vicente Jerez, Josep Ballús, Luis Álvarez-Rocha, Aránzazu Utande-Vázquez, Osvaldo Fariñas

Published in: Intensive Care Medicine | Issue 8/2012

Login to get access

Abstract

Purpose

To assess the value of (1→3)-β-d-glucan (BDG), Candida albicans germ tube antibody (CAGTA), C-reactive protein (CRP), and procalcitonin (PCT) levels for the diagnosis of invasive candidiasis (IC) and for differentiating Candida spp. colonization from infection in ICU patients with severe abdominal conditions (SAC).

Methods

Prospective study of 176 non-neutropenic patients, with SAC at ICU admission, and expected to stay at least 7 days. Surveillance cultures and BDG, CAGTA, CRP, and PCT levels were performed on the third day of ICU stay and twice a week for four consecutive weeks. Patients were grouped into invasive candidiasis (IC), Candida colonization, and neither colonized/nor infected. The classification and regression tree (CART) analysis was used to predict IC in colonized patients. The discriminatory ability of the obtained prediction rule was assessed by the area under the ROC curve (AUC).

Results

The probabilities of IC were 59.3 % for the terminal node of BDG greater than 259 pg/mL and 30.8 % for BDG less than 259 pg/mL and CAGTA positivity, whereas there was a 93.9 % probability in predicting the absence of IC for BDG less than 259 pg/mL and negative CAGTA. Using a cutoff of 30 % for IC probability, the prediction rule showed 90.3 % sensitivity, 54.8 % specificity, 42.4 % positive predictive value, and 93.9 % negative predictive value with an AUC of 0.78 (95 % confidence interval 0.76–0.81). Significant differences in CRP (p = 0.411) and PCT (p = 0.179) among the studied groups were not found.

Conclusions

BDG with a positive test for CAGTA accurately differentiated Candida colonization from IC in patients with SAC, whereas CRP and PCT did not.
Appendix
Available only for authorised users
Literature
2.
go back to reference León C, Ruiz-Santana S, Saavedra P, Almirante B, Nolla-Salas J, Alvarez-Lerma F, Garnacho-Montero J, León MA (2006) A bedside scoring system (“Candida score”) for early antifungal treatment in non-neutropenic critically ill patients with Candida colonization. Crit Care Med 34:730–737PubMedCrossRef León C, Ruiz-Santana S, Saavedra P, Almirante B, Nolla-Salas J, Alvarez-Lerma F, Garnacho-Montero J, León MA (2006) A bedside scoring system (“Candida score”) for early antifungal treatment in non-neutropenic critically ill patients with Candida colonization. Crit Care Med 34:730–737PubMedCrossRef
3.
go back to reference Ostrosky-Zeichner L, Sable C, Sobel J, Alexander BD, Donowitz G, Kan V, Kauffman CA, Kett D, Larsen RA, Morrison V, Nucci M, Pappas PG, Bradley ME, Major S, Zimmer L, Wallace D, Dismukes WE, Rex JH (2007) Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis 26:271–276PubMedCrossRef Ostrosky-Zeichner L, Sable C, Sobel J, Alexander BD, Donowitz G, Kan V, Kauffman CA, Kett D, Larsen RA, Morrison V, Nucci M, Pappas PG, Bradley ME, Major S, Zimmer L, Wallace D, Dismukes WE, Rex JH (2007) Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis 26:271–276PubMedCrossRef
4.
go back to reference León C, Ruiz-Santana S, Saavedra P, Galván B, Blanco A, Castro C, Balasini C, Utande-Vázquez A, González de Molina FJ, Blasco-Navalproto MA, López MJ, Charles PE, Martín E, Hernández-Viera MA (2009) Usefulness of the “Candida score” for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. Crit Care Med 37:1624–1633PubMedCrossRef León C, Ruiz-Santana S, Saavedra P, Galván B, Blanco A, Castro C, Balasini C, Utande-Vázquez A, González de Molina FJ, Blasco-Navalproto MA, López MJ, Charles PE, Martín E, Hernández-Viera MA (2009) Usefulness of the “Candida score” for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. Crit Care Med 37:1624–1633PubMedCrossRef
5.
go back to reference Kratzer C, Graninger W, Lassnigg A, Presterl E (2011) Design and use of Candida scores at the intensive care unit. Mycoses 54:467–474PubMedCrossRef Kratzer C, Graninger W, Lassnigg A, Presterl E (2011) Design and use of Candida scores at the intensive care unit. Mycoses 54:467–474PubMedCrossRef
6.
go back to reference Koo S, Bryar JM, Page JH, Baden LR, Marty FM (2009) Diagnostic performance of the (1→3)-beta-d-glucan assay for invasive fungal disease. Clin Infect Dis 49:1650–1659PubMedCrossRef Koo S, Bryar JM, Page JH, Baden LR, Marty FM (2009) Diagnostic performance of the (1→3)-beta-d-glucan assay for invasive fungal disease. Clin Infect Dis 49:1650–1659PubMedCrossRef
7.
go back to reference Karageorgopoulos DE, Vouloumanou EK, Ntziora F, Michalopoulos A, Rafailidis PI, Falagas ME (2011) β-d-Glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clin Infect Dis 52:750–770PubMedCrossRef Karageorgopoulos DE, Vouloumanou EK, Ntziora F, Michalopoulos A, Rafailidis PI, Falagas ME (2011) β-d-Glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clin Infect Dis 52:750–770PubMedCrossRef
8.
go back to reference Moragues MD, Ortiz N, Iruretagoyena JR, García-Ruiz JC, Amutio E, Rojas A, Mendoza J, Quindós G, Pontón-San Emeterio J (2004) Evaluation of a new commercial test (Candida albicans IFA IgG) for the serodiagnosis of invasive candidiasis. Enferm Infecc Microbiol Clin 22:83–88PubMed Moragues MD, Ortiz N, Iruretagoyena JR, García-Ruiz JC, Amutio E, Rojas A, Mendoza J, Quindós G, Pontón-San Emeterio J (2004) Evaluation of a new commercial test (Candida albicans IFA IgG) for the serodiagnosis of invasive candidiasis. Enferm Infecc Microbiol Clin 22:83–88PubMed
9.
go back to reference Zaragoza R, Pemán J, Quindós G, Iruretagoyena JR, Cuétara MS, Ramírez P, Gómez MD, Camarena JJ, Viudes A, Pontón J (2009) Clinical significance of the detection of Candida albicans germ tube-specific antibodies in critically ill patients. Clin Microbiol Infect 15:592–595PubMedCrossRef Zaragoza R, Pemán J, Quindós G, Iruretagoyena JR, Cuétara MS, Ramírez P, Gómez MD, Camarena JJ, Viudes A, Pontón J (2009) Clinical significance of the detection of Candida albicans germ tube-specific antibodies in critically ill patients. Clin Microbiol Infect 15:592–595PubMedCrossRef
10.
go back to reference Pemán J, Zaragoza R, Quindós R, Alkorta M, Cuétara MS, Camarena JJ, Ramírez P, Giménez MJ, Martín-Mazuelos E, Linares-Sicilia MJ, Pontón J (2011) Clinical factors associated with a Candida albicans germ tube antibody positive test in intensive care unit patients. BMC Infect Dis 11:60. doi:10.1186/1471-2334-11-60 PubMedCrossRef Pemán J, Zaragoza R, Quindós R, Alkorta M, Cuétara MS, Camarena JJ, Ramírez P, Giménez MJ, Martín-Mazuelos E, Linares-Sicilia MJ, Pontón J (2011) Clinical factors associated with a Candida albicans germ tube antibody positive test in intensive care unit patients. BMC Infect Dis 11:60. doi:10.​1186/​1471-2334-11-60 PubMedCrossRef
11.
go back to reference Povoa PR, Teixeira-Pinto AM, Carneiro AH (2011) C-reactive protein, an early marker of community-acquired sepsis resolution: a multi-center prospective observational study. Crit Care 15:R169PubMedCrossRef Povoa PR, Teixeira-Pinto AM, Carneiro AH (2011) C-reactive protein, an early marker of community-acquired sepsis resolution: a multi-center prospective observational study. Crit Care 15:R169PubMedCrossRef
12.
go back to reference Charles PE, Castro C, Ruiz-Santana S, León C, Saavedra P, Martín E (2009) Serum procalcitonin levels in critically ill patients colonized with Candida spp: new clues for the early recognition of invasive candidiasis? Intensive Care Med 35:2146–2150PubMedCrossRef Charles PE, Castro C, Ruiz-Santana S, León C, Saavedra P, Martín E (2009) Serum procalcitonin levels in critically ill patients colonized with Candida spp: new clues for the early recognition of invasive candidiasis? Intensive Care Med 35:2146–2150PubMedCrossRef
14.
go back to reference Charles PE, Dalle F, Aube H, Doise JM, Quenot JP, Aho LS, Chavanet P, Blettery B (2005) Candida spp. colonization significance in critically ill medical patients: a prospective study. Intensive Care Med 31:393–400PubMedCrossRef Charles PE, Dalle F, Aube H, Doise JM, Quenot JP, Aho LS, Chavanet P, Blettery B (2005) Candida spp. colonization significance in critically ill medical patients: a prospective study. Intensive Care Med 31:393–400PubMedCrossRef
15.
go back to reference León C, Alvarez-Lerma F, Ruiz-Santana S, León MA, Nolla J, Jordá R, Saavedra P, Palomar M (2009) Fungal colonization and/or infection in non-neutropenic critically ill patients: results of the EPCAN observational study. Eur J Clin Microbiol Infect Dis 28:233–242PubMedCrossRef León C, Alvarez-Lerma F, Ruiz-Santana S, León MA, Nolla J, Jordá R, Saavedra P, Palomar M (2009) Fungal colonization and/or infection in non-neutropenic critically ill patients: results of the EPCAN observational study. Eur J Clin Microbiol Infect Dis 28:233–242PubMedCrossRef
16.
go back to reference De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Muñoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46:1813–1822PubMedCrossRef De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Muñoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46:1813–1822PubMedCrossRef
17.
18.
go back to reference Oude Lashof AM, Rothova A, Sobel JD, Ruhnke M, Pappas PG, Viscoli C, Schlamm HT, Oborska IT, Rex JH, Kullberg BJ (2011) Ocular manifestations of candidemia. Clin Infect Dis 53:262–268PubMedCrossRef Oude Lashof AM, Rothova A, Sobel JD, Ruhnke M, Pappas PG, Viscoli C, Schlamm HT, Oborska IT, Rex JH, Kullberg BJ (2011) Ocular manifestations of candidemia. Clin Infect Dis 53:262–268PubMedCrossRef
19.
go back to reference Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 49:1–45PubMedCrossRef Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 49:1–45PubMedCrossRef
20.
go back to reference Breiman L, Freidman JH, Olshen RA, Stone CJ (1984) Classification and regression trees. Wadsworth, Belmont Breiman L, Freidman JH, Olshen RA, Stone CJ (1984) Classification and regression trees. Wadsworth, Belmont
21.
go back to reference Digby J, Kalbfleisch J, Glenn A, Larsen A, Browder W, Williams D (2003) Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients. Clin Diagn Lab Immunol 10:882–885PubMed Digby J, Kalbfleisch J, Glenn A, Larsen A, Browder W, Williams D (2003) Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients. Clin Diagn Lab Immunol 10:882–885PubMed
22.
go back to reference Takesue Y, Kakehashi M, Ohge H, Imamura Y, Murakami Y, Sasaki M, Morifuji M, Yokoyama Y, Kouyama M, Yokoyama T, Sueda T (2004) Combined assessment of beta-d-glucan and degree of Candida colonization before starting empiric therapy for candidiasis in surgical patients. World J Surg 28:625–630PubMedCrossRef Takesue Y, Kakehashi M, Ohge H, Imamura Y, Murakami Y, Sasaki M, Morifuji M, Yokoyama Y, Kouyama M, Yokoyama T, Sueda T (2004) Combined assessment of beta-d-glucan and degree of Candida colonization before starting empiric therapy for candidiasis in surgical patients. World J Surg 28:625–630PubMedCrossRef
23.
go back to reference Acosta J, Catalan M, Del Palacio-Peréz-Medel A, Lora D, Montejo JC, Cuetara MS, Moragues MD, Ponton J, del Palacio A (2011) A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1→3)-β-d-glucan chromogenic assay in serum samples. Clin Microbiol Infect 17:1053–1060PubMedCrossRef Acosta J, Catalan M, Del Palacio-Peréz-Medel A, Lora D, Montejo JC, Cuetara MS, Moragues MD, Ponton J, del Palacio A (2011) A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1→3)-β-d-glucan chromogenic assay in serum samples. Clin Microbiol Infect 17:1053–1060PubMedCrossRef
24.
go back to reference Posteraro B, De Pascale G, Tumbarello M, Torelli R, Pennisi MA, Bello G, Maviglia R, Fadda G, Sanguinetti M, Antonelli M (2011) Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-beta-d-glucan assay, Candida score, and colonization index. Crit Care 15:R249. doi:10.1186/cc10507 PubMedCrossRef Posteraro B, De Pascale G, Tumbarello M, Torelli R, Pennisi MA, Bello G, Maviglia R, Fadda G, Sanguinetti M, Antonelli M (2011) Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-beta-d-glucan assay, Candida score, and colonization index. Crit Care 15:R249. doi:10.​1186/​cc10507 PubMedCrossRef
25.
go back to reference Mohr JF, Sims Ch, Paetznick V, Rodriguez J, Finkelman MA, Rex JH, Ostrosky-Zeichner L (2011) A prospective survey of (1→3)-β-d-glucan and its relationship to invasive candidiasis in the surgical ICU setting. J Clin Microbiol 49:58–61PubMedCrossRef Mohr JF, Sims Ch, Paetznick V, Rodriguez J, Finkelman MA, Rex JH, Ostrosky-Zeichner L (2011) A prospective survey of (1→3)-β-d-glucan and its relationship to invasive candidiasis in the surgical ICU setting. J Clin Microbiol 49:58–61PubMedCrossRef
26.
go back to reference Onishi A, Sugiyama D, Kogata Y, Saegusa J, Sugimoto T, Kawano S, Morinobu A, Nishimura K, Kumagai S (2012) Diagnostic accuracy of serum 1,3-β-d-glucan for Pneumocystis jirovecii pneumonia, invasive candidiasis and invasive aspergillosis: systematic review and meta-analysis. J Clin Microbiol 50:7–15PubMedCrossRef Onishi A, Sugiyama D, Kogata Y, Saegusa J, Sugimoto T, Kawano S, Morinobu A, Nishimura K, Kumagai S (2012) Diagnostic accuracy of serum 1,3-β-d-glucan for Pneumocystis jirovecii pneumonia, invasive candidiasis and invasive aspergillosis: systematic review and meta-analysis. J Clin Microbiol 50:7–15PubMedCrossRef
27.
go back to reference Albert O, Toubas D, Strady C, Cousson J, Delmas C, Vernet V, Villena I (2011) Reactivity of (1→3)-β-d-glucan assay in bacterial bloodstream infections. Eur J Clin Microbiol Infect 30:1453–1460CrossRef Albert O, Toubas D, Strady C, Cousson J, Delmas C, Vernet V, Villena I (2011) Reactivity of (1→3)-β-d-glucan assay in bacterial bloodstream infections. Eur J Clin Microbiol Infect 30:1453–1460CrossRef
28.
go back to reference Metan G, Agkus C, Nedret Koc A, Elmali F, Finkelman MA (2011) Does ampicillin-sulbactam cause false positivity of (1,3)-beta-d-glucan assay? A prospective evaluation of 15 patients without invasive fungal infections. Mycoses. doi:10.1111/j.1439-0507.2011.02131.x PubMed Metan G, Agkus C, Nedret Koc A, Elmali F, Finkelman MA (2011) Does ampicillin-sulbactam cause false positivity of (1,3)-beta-d-glucan assay? A prospective evaluation of 15 patients without invasive fungal infections. Mycoses. doi:10.​1111/​j.​1439-0507.​2011.​02131.​x PubMed
29.
go back to reference Pickering JW, Sant HW, Bowles CA, Roberts WL, Woods GL (2005) Evaluation of a (1→3)-beta-d-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 43:5957–5962PubMedCrossRef Pickering JW, Sant HW, Bowles CA, Roberts WL, Woods GL (2005) Evaluation of a (1→3)-beta-d-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 43:5957–5962PubMedCrossRef
30.
go back to reference Presterl E, Parschalk B, Bauer E, Lassnigg A, Hajdu S, Graninger W (2009) Invasive fungal infections and (1,3)-beta-d-glucan serum concentrations in long-term intensive care patients. Int J Infect Dis 13:707–1712 Presterl E, Parschalk B, Bauer E, Lassnigg A, Hajdu S, Graninger W (2009) Invasive fungal infections and (1,3)-beta-d-glucan serum concentrations in long-term intensive care patients. Int J Infect Dis 13:707–1712
31.
go back to reference Nguyen MH, Wissel MC, Shields RK, Salomoni MA, Hao B, Press EG, Shields RM, Cheng S, Mitsani D, Vadnerkar A, Silveira FP, Kleiboeker SB, Clancy CJ (2012) Performance of Candida real-time polymerase chain reaction, β-d-glucan assay, and blood cultures in the diagnosis of invasive candidiasis. Clin Infect Dis 54:1240–1248PubMedCrossRef Nguyen MH, Wissel MC, Shields RK, Salomoni MA, Hao B, Press EG, Shields RM, Cheng S, Mitsani D, Vadnerkar A, Silveira FP, Kleiboeker SB, Clancy CJ (2012) Performance of Candida real-time polymerase chain reaction, β-d-glucan assay, and blood cultures in the diagnosis of invasive candidiasis. Clin Infect Dis 54:1240–1248PubMedCrossRef
Metadata
Title
Value of β-d-glucan and Candida albicans germ tube antibody for discriminating between Candida colonization and invasive candidiasis in patients with severe abdominal conditions
Authors
Cristóbal León
Sergio Ruiz-Santana
Pedro Saavedra
Carmen Castro
Alejandro Úbeda
Ana Loza
Estrella Martín-Mazuelos
Armando Blanco
Vicente Jerez
Josep Ballús
Luis Álvarez-Rocha
Aránzazu Utande-Vázquez
Osvaldo Fariñas
Publication date
01-08-2012
Publisher
Springer-Verlag
Published in
Intensive Care Medicine / Issue 8/2012
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-012-2616-y

Other articles of this Issue 8/2012

Intensive Care Medicine 8/2012 Go to the issue